Nov. 21, 2024 (GLOBE NEWSWIRE) -- Claimable, a pioneering healthcare technology company, today announced the launch of its free AI-powered appeals platform designed to help children with PANS/PANDAS ...
today announced the launch of its free AI-powered appeals platform designed to help children with PANS/PANDAS overcome insurance denials and access critical intravenous immunoglobulin (IVIG ...
Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune system functions poorly. It is made from human blood plasma and is ...
Total IgG levels were determined in serum samples pretreatment and again 2 weeks after treatment. Some patients also had IgG levels measured at 4 weeks (91 patients), 3 months (86 patients), and 6 ...
With many patients, a critical element of treatment is infusion of intravenous immune globulin (IVIG). Congress should ensure that comparative effectiveness research does not allow for cost ...
Immunoglobulin-based therapies ... and their receptors Patients with rheumatic diseases could benefit from IVIg therapy since it behaves as a single drug with multiple targets The mechanisms ...
A number of treatment trials have demonstrated benefit ... compared two of the more commonly used therapies for CIDP: IV immunoglobulin (IVIg) and IV methylprednisolone. The authors performed ...